Timely Topics in Transplantation
Timely topics in transplantation presented by expert faculty.
Timely Topics in Transplantation (T3) webinars are the perfect opportunity to listen to a live presentation by expert faculty on a current issue in transplantation. Live attendees are encouraged to participate by submitting questions to help shape the Q&A discussion featured in each session.
What makes the Timely Topics in Transplantation webinar series so relevant to the interests of transplant professionals? T3 webinars are developed by the AST Education Committee in partnership with the AST Communities of Practice. Every year, new webinars are added to the series, featuring topics identified by COP and Committee leaders as the most important to transplant professionals.
All T3 webinars are $25 per session, but free to AST members as part of their member benefits package. All webinars are available on-demand after the live air date.
Registration for 2025-2026 T3 series webinars will open soon! The series is expected to include expert presentations and discussion on:
- Navigating Biologic Therapies for Non-Transplant Indications in Solid Organ Transplant Recipients
- Addressing sex-based disparities in access to solid organ transplantation
- What we know about the CMS OPO Performance Metrics that you need to know as a Transplant Professional
- Navigating Change: Strategies for Successful Transition from Adolescent to Adult Care in Solid Organ Transplant Recipients
- ...and more!
Learn about the cost implications, logistics, and impact of Ex Situ Machine Perfusion (ESMP) and Normothermic Regional Perfusion (NRP), their pros and cons, and future perspectives.
2:00 PM - 3:00 PM EDT
Learn about the barriers that AYA transplant recipients and their healthcare providers encounter during the transition from pediatric to adult care, explore the unique challenges, and compare strategies promoting continuity of care.
Learn more about the CMS Final Rule for OPOs. Join our experts to review evidence-based research on implications, processes, and outcomes of the rule for OPOs, transplant centers, and our system.
Learn more about non-transplant biologics used for the treatment of inflammatory disease states, and join our expert panel for a discussion on the safety of these agents for transplant patients and best practices for when they are needed.
On-demand: T3 Series
Browse the T3 series by year.
The 2024-2025 T3 Series
Covering Xenotransplantation, Utilizing GLP-1 Agonists, NRP vs. Ex-Vivo MP, and more!
The 2023-2024 T3 Series
Covering A.I. & Transplantation, Phage Therapy in SOT, DCUs, Post-transplant Malignancy Treatments, and more.
The 2022-2023 T3 Series
Covering Medicare Part B-ID, Donor-Derived Infections, Care of the Transgender Recipient, Xenotransplantation, and more.
The 2021-2022 T3 Series
Covering Management of Multidrug Resistant Organisms, Xenotransplantation: Pig to Human Heart Transplant, and more.
The 2020-2021 T3 Series
Covering Biomarkers and Gene Expression, Optimizing Vaccination, Frailty, and more.
The 2019-2020 T3 Series
Covering Non-invasive Biomarkers, Diagnostic Stewardship, Advanced Technology in Transplant Care, and more.
The 2018-2019 T3 Series
Covering Living Kidney Donation, Pharmacogenomics,, QAPI, an more.
The 2017-2018 T3 Series
Covering Optimizing Viral Diagnostics, Vaccinations, and more.
The 2015-2016 T3 Series
Covering Management of Immunosuppression, Donor-specific Antibody Testing, and more.
The 2014-2015 T3 Series
Covering Hep C Treatment in SOT Recipients, Monitoring Alloresponse, and more.
Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk.
Advertisements
